Skip to content

Clinical trials

Phase 1/2 Lymphoma, Large B-Cell, Diffuse trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Phase: Phase 1/2 Clear all

222 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20012
20022
20035
20044
20058
20065
20072
20089
20095
20108
20116
20124
20138
20148
201510
201616
201715
20186
20196
202016
202111
202212
202311
20246
202511
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed88
Terminated37
Recruiting32
Active, not recruiting23
Unknown status21
Withdrawn11
Not yet recruiting7
Suspended3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)11
Fred Hutchinson Cancer Center10
Mayo Clinic7
Northwestern University6
University of Washington5
Genmab4
Hoffmann-La Roche4
Incyte Corporation4
M.D. Anderson Cancer Center4
Masonic Cancer Center, University of Minnesota4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse222
Lymphoma, Follicular105
Lymphoma, Mantle-Cell94
Lymphoma, Non-Hodgkin86
Lymphoma78
Leukemia, Lymphocytic, Chronic, B-Cell75
Lymphoma, B-Cell, Marginal Zone60
Burkitt Lymphoma55
Precursor Cell Lymphoblastic Leukemia-Lymphoma50
Hodgkin Disease41

Trials

Showing 76 to 100 of 222. Each trial links to its page on Pharma Observatory.

122 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.